// COMPANY
Flagship Pioneering
SECTOR VENTURE CAPITALMENTIONS 3LAST SEEN AUGUST 28, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
3 SIGNALS
01
mention·Axios Pro Rata·AUGUST 28, 2026
“University R&D funding is 'being increasingly threatened by puerile politics.' Given that Revolution Medicines (Third Rock, University of Illinois) and Moderna (Flagship Pioneering) both trace directly to academic research”
02
03
m_and_a·Axios Pro Rata·JULY 30, 2026
“Johnson & Johnson is investing $785m into Sail Biomedicines, a Cambridge, Mass.-based CAR-T cell therapy developer formed by Flagship Pioneering, via a deal that also gives J&J an acquisition option.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.